As of close of business last night, Inspire Medical Systems Inc’s stock clocked out at $210.19, up 2.50% from its previous closing price of $205.06. In other words, the price has increased by $+5.13 from its previous closing price. On the day, 632916 shares were traded.
Ratios:
To gain a deeper understanding of INSP’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6097.57. For the most recent quarter (mrq), Quick Ratio is recorded 7.17 and its Current Ratio is at 7.60. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on March 19, 2024, initiated with a Overweight rating and assigned the stock a target price of $250.
On January 19, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $245.Jefferies initiated its Buy rating on January 19, 2024, with a $245 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’24 when Herbert Timothy P. sold 40,000 shares for $205.09 per share. The transaction valued at 8,203,581 led to the insider holds 63,658 shares of the business.
Griffin Jerry C sold 32 shares of INSP for $6,848 on Apr 01 ’24. The Director now owns 10,900 shares after completing the transaction at $213.99 per share. On Mar 25 ’24, another insider, Griffin Jerry C, who serves as the Director of the company, sold 554 shares for $197.81 each. As a result, the insider received 109,587 and left with 10,636 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 6.21B and an Enterprise Value of 5.78B. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.95 while its Price-to-Book (P/B) ratio in mrq is 10.85. Its current Enterprise Value per Revenue stands at 9.25 whereas that against EBITDA is -338.64.
Stock Price History:
Over the past 52 weeks, INSP has reached a high of $330.00, while it has fallen to a 52-week low of $123.27. The 50-Day Moving Average of the stock is 199.12, while the 200-Day Moving Average is calculated to be 209.12.
Shares Statistics:
It appears that INSP traded 509.54K shares on average per day over the past three months and 505.26k shares per day over the past ten days. A total of 29.56M shares are outstanding, with a floating share count of 28.92M. Insiders hold about 2.24% of the company’s shares, while institutions hold 105.04% stake in the company. Shares short for INSP as of Mar 15, 2024 were 1.87M with a Short Ratio of 3.67, compared to 1.77M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.16% and a Short% of Float of 7.06%.
Earnings Estimates
As of right now, 16 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.65 for the current quarter, with a high estimate of -$0.41 and a low estimate of -$0.85, while EPS last year was -$0.53. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.06 and low estimates of -$0.5.
Analysts are recommending an EPS of between $0.21 and -$1.17 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is $0.62, with 17 analysts recommending between $2.41 and -$0.33.
Revenue Estimates
In the current quarter, 16 analysts expect revenue to total $161.31M. It ranges from a high estimate of $163.9M to a low estimate of $159.7M. As of the current estimate, Inspire Medical Systems Inc’s year-ago sales were $127.9M, an estimated increase of 26.10% from the year-ago figure.
A total of 17 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $796.1M, while the lowest revenue estimate was $775M, resulting in an average revenue estimate of $782.27M. In the same quarter a year ago, actual revenue was $624.8M, up 25.20% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $950.91M in the next fiscal year. The high estimate is $996.85M and the low estimate is $899.59M. The average revenue growth estimate for next year is up 21.60% from the average revenue estimate for this year.
